News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cordis Corporation (JNJ) Announces Two-Year Results From the STROLL Trial


1/22/2013 10:18:07 AM

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cordis Corporation today announced the presentation of the two-year STROLL study results at the Abstracts and Late Breaking Clinical Trials session at ISET 2013. William A. Gray, MD, Director of Endovascular Services, Cardiovascular Research Foundation, New York, presented the results of the STROLL study (S.M.A.R.T.® Vascular Stent Systems in the TReatment of Obstructive SuperficiaL FemoraL Artery Disease) on behalf of the study investigators. The STROLL study assessed the safety and efficacy of the S.M.A.R.T.® Vascular Stent Systems (S.M.A.R.T.® Stent) in treating patients with obstructive superficial femoral artery (SFA) disease.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES